Showing results (1741-1750 of 2,369) with videos related to
Sort By:
Pageof 237
Future Medicinal Chemistry|June 11, 2026
Hybridization of isatin and benzoxazolinone via a diethyl spacer: a new scaffold for breast cancer drug discoveryGarima Chauhan, Sahil Kumar, Dharam Pal Pathak, et al.Future Medicinal Chemistry|June 12, 2026
Synthesis, biological profiling, and computational investigation of 1,2,4-triazole-5-thione-quinoline Schiff base hybridsErgün Gültekin, Hacer Doğan, Abdurrahman Atalay, et al.Future Medicinal Chemistry|June 9, 2026
A comprehensive exploration of the structure-activity relationships, multitarget strategies, and therapeutic mechanisms of triazole scaffolds in Alzheimer's diseaseAafreen Malvankar, Mahesh Raut, Sushil Kumar Singh, et al.Future Medicinal Chemistry|May 21, 2010
Nanomedicine strategies for molecular targets with MRI and optical imagingDipanjan Pan, Shelton D Caruthers, Junjie Chen, et al.Future Medicinal Chemistry|March 25, 2011
Bionanotechnology: small can have a big impact in the medical sciences: a WIN-win situation. Part 2John F Honek, Alain Francq, Arthur J CartyFuture Medicinal Chemistry|July 11, 2026
Oxazole-4,5-dicarboxylate derivatives as multifunctional targets against oral cancer and Streptococcus mutans oral pathogensTamilvelan Manjunathan, Ajay GuruFuture Medicinal Chemistry|July 13, 2026
Unlocking new antimicrobial leads in the last decade: exploring quinolin-2-one based hybrids' synthesis, action, SAR, and challenges in tackling antimicrobial resistanceMahmoud Alaaeldin Khattab, Mai I Shahin, Azza T Taher, et al.Future Medicinal Chemistry|June 25, 2026
Indole-based carbohydrazides as potent anti-proliferative leads and tubulin polymerization inhibitors: design, synthesis, cytotoxic evaluation, in silico ADMET and docking studiesAisha A Alsfouk, Eman S Nossier, Mohamed Omar, et al.Future Medicinal Chemistry|June 21, 2017
3-(Benzyloxy)-1-(5-[18F]fluoropentyl)-5-nitro-1H-indazole: a PET radiotracer to measure acetylcholinesterase in brainSoledad Fernández, Javier Giglio, Ana Laura Reyes, et al.Future Medicinal Chemistry|May 11, 2012
Is RAGE still a therapeutic target for Alzheimer's disease?Richard J DeanePageof 237